Back to Search

JENNIFER KING, BSW, CADCII

BSW, CADCII

Addiction (Substance Use Disorder) Counselor

NPI: 1932569563Individual

Specialties, Licenses & Credentials

Addiction (Substance Use Disorder) CounselorPrimary

Counselor — Addiction (Substance Use Disorder)

Code: 101YA0400X

Clinical Trials (2)

2
Linked Trials
0
Recruiting
2
With Results

Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women

NCT00869960COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

The Bioequivalence of Atripla in an Oral Liquid Formulation Compared With the Tablet Formulation in Healthy Volunteers

NCT00862823COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (1)

A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet.
PMID 22046602·J Acquir Immune Defic Syndr·2011
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
149 S MAIN ST
PHOENIX, OR 97535

Quick Facts

NPI
1932569563
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Clinical Trials
2
Publications
1

Are you this provider?

Claim Your Profile